Author
Listed:
- J. A. Hurcombe
(University of Bristol)
- P. Hartley
(Bournemouth University)
- A. C. Lay
(University of Bristol)
- L. Ni
(University of Bristol)
- J. J. Bedford
(University of Otago)
- J. P. Leader
(University of Otago)
- S. Singh
(University of Bristol)
- A. Murphy
(Southern General Hospital)
- C. L. Scudamore
(Mary Lyon Centre, MRC Harwell, Didcot)
- E. Marquez
(University of Bristol)
- A. F. Barrington
(University of Bristol)
- V. Pinto
(University of Bristol)
- M. Marchetti
(University of Bristol)
- L.-F. Wong
(University of Bristol)
- J. Uney
(University of Bristol)
- M. A. Saleem
(University of Bristol)
- P. W. Mathieson
(University of Bristol
The University of Hong Kong)
- S. Patel
(Sinai Health System & University of Toronto
University of Cambridge)
- R. J. Walker
(University of Otago)
- J. R. Woodgett
(Sinai Health System & University of Toronto)
- S. E. Quaggin
(Northwestern University Feinberg School of Medicine)
- G. I. Welsh
(University of Bristol)
- R. J. M. Coward
(University of Bristol)
Abstract
Albuminuria affects millions of people, and is an independent risk factor for kidney failure, cardiovascular morbidity and death. The key cell that prevents albuminuria is the terminally differentiated glomerular podocyte. Here we report the evolutionary importance of the enzyme Glycogen Synthase Kinase 3 (GSK3) for maintaining podocyte function in mice and the equivalent nephrocyte cell in Drosophila. Developmental deletion of both GSK3 isoforms (α and β) in murine podocytes causes late neonatal death associated with massive albuminuria and renal failure. Similarly, silencing GSK3 in nephrocytes is developmentally lethal for this cell. Mature genetic or pharmacological podocyte/nephrocyte GSK3 inhibition is also detrimental; producing albuminuric kidney disease in mice and nephrocyte depletion in Drosophila. Mechanistically, GSK3 loss causes differentiated podocytes to re-enter the cell cycle and undergo mitotic catastrophe, modulated via the Hippo pathway but independent of Wnt-β-catenin. This work clearly identifies GSK3 as a critical regulator of podocyte and hence kidney function.
Suggested Citation
J. A. Hurcombe & P. Hartley & A. C. Lay & L. Ni & J. J. Bedford & J. P. Leader & S. Singh & A. Murphy & C. L. Scudamore & E. Marquez & A. F. Barrington & V. Pinto & M. Marchetti & L.-F. Wong & J. Uney, 2019.
"Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function,"
Nature Communications, Nature, vol. 10(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08235-1
DOI: 10.1038/s41467-018-08235-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08235-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.